U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807228) titled 'Changes in Skin Myco- and Microbiome After Lebrikizumab Treatment' on June 23.
Brief Summary: The goal of this observational study is to characterize the skin myco- and microbiome of patients with atopic dermatitis before and after initiation of treatment with lebrikizumab. The main questions it aims to answer are:
Does the skin mycobiome change with treatment? Does the skin microbiome change with treatment? Does the abundance of Staphylococcus species change with treatment?
Study Start Date: June 05, 2025
Study Type: OBSERVATIONAL
Condition:
Atopic Dermatitis
Recruitment Status: RECRUITING
Sponsor: University Hospital Bispeb...